Clinical Trial Update: SU5416 and Irinotecan in Treating Patients With Advanced Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

An update on a Phase 1/2 trial of SU5416 in combination with Irinotecan for advanced colorectal cancer, with the study status showing completion across several …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Colon
• Adenocarcinoma of the Rectum
• Colon Cancer
• Rectal Cancer

Drugs mentioned

• Irinotecan (Irinotecan)
• SU5416 (semaxanib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum | Phase 1, Phase 2 | Status: COMPLETED